Boccalini, S.; Zanella, B.; Landa, P.; Amicizia, D.; Bechini, A.; Innocenti, M.; Iovine, M.; Lecini, E.; Marchini, F.; Paolini, D.;
et al. Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence. Microorganisms 2020, 8, 1681.
https://doi.org/10.3390/microorganisms8111681
AMA Style
Boccalini S, Zanella B, Landa P, Amicizia D, Bechini A, Innocenti M, Iovine M, Lecini E, Marchini F, Paolini D,
et al. Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence. Microorganisms. 2020; 8(11):1681.
https://doi.org/10.3390/microorganisms8111681
Chicago/Turabian Style
Boccalini, Sara, Beatrice Zanella, Paolo Landa, Daniela Amicizia, Angela Bechini, Maddalena Innocenti, Mariasilvia Iovine, Elvina Lecini, Francesca Marchini, Diana Paolini,
and et al. 2020. "Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence" Microorganisms 8, no. 11: 1681.
https://doi.org/10.3390/microorganisms8111681
APA Style
Boccalini, S., Zanella, B., Landa, P., Amicizia, D., Bechini, A., Innocenti, M., Iovine, M., Lecini, E., Marchini, F., Paolini, D., Sartor, G., Zangrillo, F., Lai, P. L., Bonanni, P., & Panatto, D.
(2020). Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence. Microorganisms, 8(11), 1681.
https://doi.org/10.3390/microorganisms8111681